{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:00:55Z","timestamp":1790913655159,"version":"4.1.0"},"reference-count":129,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T00:00:00Z","timestamp":1585526400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T00:00:00Z","timestamp":1585526400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Non coding RNAs (ncRNAs) have emerged as regulators of human carcinogenesis by affecting the expression of key tumor suppressor genes and oncogenes. They are divided into short and long ncRNAs, according to their length. Circular RNAs (circRNAs) are included in the second group and were recently discovered as being originated by back-splicing, joining either single or multiple exons, or exons with retained introns. The human\n                    <jats:italic>Plasmacytoma Variant Translocation 1<\/jats:italic>\n                    (\n                    <jats:italic>PVT1<\/jats:italic>\n                    ) gene maps on the long arm of chromosome 8 (8q24) and encodes for 52 ncRNAs variants, including 26 linear and 26 circular isoforms, and 6 microRNAs.\n                    <jats:italic>PVT1<\/jats:italic>\n                    genomic locus is 54 Kb downstream to\n                    <jats:italic>MYC<\/jats:italic>\n                    and several interactions have been described among these two genes, including a feedback regulatory mechanism.\n                    <jats:italic>MYC<\/jats:italic>\n                    -independent functions of\n                    <jats:italic>PVT1<\/jats:italic>\n                    \/\n                    <jats:italic>circPVT1<\/jats:italic>\n                    have been also reported, especially in the regulation of immune responses. We here review and discuss the role of both\n                    <jats:italic>PVT1<\/jats:italic>\n                    and\n                    <jats:italic>circPVT1<\/jats:italic>\n                    in the hematopoietic system. No information is currently available concerning their transforming ability in hematopoietic cells. However, present literature supports their cooperation with a more aggressive and\/or undifferentiated cell phenotype, thus contributing to cancer progression.\n                    <jats:italic>PVT1<\/jats:italic>\n                    \/\n                    <jats:italic>circPVT1<\/jats:italic>\n                    upregulation through genomic amplification or rearrangements and\/or increased transcription, provides a proliferative advantage to malignant cells in acute myeloid leukemia, acute promyelocytic leukemia, Burkitt lymphoma, multiple myeloma (linear\n                    <jats:italic>PVT1<\/jats:italic>\n                    ) and acute lymphoblastic leukemia (\n                    <jats:italic>circPVT1<\/jats:italic>\n                    ). In addition,\n                    <jats:italic>PVT1<\/jats:italic>\n                    and\n                    <jats:italic>circPVT1<\/jats:italic>\n                    regulate immune responses: the overexpression of the linear form in myeloid derived suppressor cells induced immune tolerance in preclinical tumor models and\n                    <jats:italic>circPVT1<\/jats:italic>\n                    showed immunosuppressive properties in myeloid and lymphoid cell subsets. Overall, these recent data on\n                    <jats:italic>PVT1<\/jats:italic>\n                    and\n                    <jats:italic>circPVT1<\/jats:italic>\n                    functions in hematological malignancies and immune responses reflect two faces of the same coin: involvement in cancer progression by promoting a more aggressive phenotype of malignant cells and negative regulation of the immune system as a novel potential therapy-resistance mechanism.\n                  <\/jats:p>","DOI":"10.1186\/s12943-020-01187-5","type":"journal-article","created":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T05:03:57Z","timestamp":1585544637000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":73,"title":["Linear and circular PVT1 in hematological malignancies and immune response: two faces of the same coin"],"prefix":"10.1186","volume":"19","author":[{"given":"Martina","family":"Ghetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Vannini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clelia Tiziana","family":"Storlazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Martinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Simonetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,30]]},"reference":[{"key":"1187_CR1","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1073\/pnas.0307323101","volume":"101","author":"GA Calin","year":"2004","unstructured":"Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A. 2004;101:2999\u20133004.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1187_CR2","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.ccr.2007.07.027","volume":"12","author":"GA Calin","year":"2007","unstructured":"Calin GA, Gong LC, Ferracin M, Hyslop T, Spizzo R, Sevignani C, et al. Ultraconserved regions encoding ncRNAs are altered in human Leukemias and carcinomas. Cancer Cell. 2007;12:215\u201329 Cell Press.","journal-title":"Cancer Cell"},{"key":"1187_CR3","doi-asserted-by":"crossref","unstructured":"Sanchez Calle A, Kawamura Y, Yamamoto Y, Takeshita F, Ochiya T. Emerging roles of long non-coding RNA in cancer. Cancer Sci, Blackwell Publishing Ltd. 2018;109:2093\u2013100.","DOI":"10.1111\/cas.13642"},{"key":"1187_CR4","doi-asserted-by":"crossref","unstructured":"Vannini I, Fanini F, Fabbri M. Emerging roles of microRNAs in cancer. Curr Opin Genet Dev, Elsevier Ltd. 2018;48:128\u201333.","DOI":"10.1016\/j.gde.2018.01.001"},{"key":"1187_CR5","doi-asserted-by":"crossref","unstructured":"Spizzo R, Almeida MI, Colombatti A, Calin GA. Long non-coding RNAs and cancer: A new frontier of translational research. Oncogene. 2012;31:4577\u201387.","DOI":"10.1038\/onc.2011.621"},{"key":"1187_CR6","doi-asserted-by":"crossref","unstructured":"Ulitsky I, Bartel DP. XLincRNAs: Genomics, evolution, and mechanisms. Cell. 2013;154(1):26\u201346 Cell Press.","DOI":"10.1016\/j.cell.2013.06.020"},{"key":"1187_CR7","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1101\/gr.156612.113","volume":"23","author":"TR Mercer","year":"2013","unstructured":"Mercer TR, Mattick JS. Understanding the regulatory and transcriptional complexity of the genome through structure. Genome Res. 2013;23:1081\u20138.","journal-title":"Genome Res"},{"key":"1187_CR8","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/s41467-017-02485-1","volume":"9","author":"I Vannini","year":"2018","unstructured":"Vannini I, Wise PM, Challagundla KB, Plousiou M, Raffini M, Bandini E, et al. Publisher correction: transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs. Nat Commun. 2018;9:160.","journal-title":"Nat Commun"},{"key":"1187_CR9","doi-asserted-by":"crossref","unstructured":"Ebbesen KK, Hansen TB, Kjems J. Insights into circular RNA biology. RNA Biol. 2017; 14(8):1035\u201345 Taylor and Francis Inc.","DOI":"10.1080\/15476286.2016.1271524"},{"key":"1187_CR10","doi-asserted-by":"crossref","unstructured":"Li X, Yang L, Chen LL. The Biogenesis, Functions, and Challenges of Circular RNAs. Mol Cell. 2018;71:428\u201342 Cell Press.","DOI":"10.1016\/j.molcel.2018.06.034"},{"key":"1187_CR11","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1080\/15476286.2017.1409931","volume":"15","author":"LS Kristensen","year":"2018","unstructured":"Kristensen LS, Okholm TLH, Ven\u00f8 MT, Kjems J. Circular RNAs are abundantly expressed and upregulated during human epidermal stem cell differentiation. RNA Biol. 2018;15:280\u201391 Taylor and Francis Inc.","journal-title":"RNA Biol"},{"key":"1187_CR12","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.cell.2019.03.046","volume":"177","author":"CX Liu","year":"2019","unstructured":"Liu CX, Li X, Nan F, Jiang S, Gao X, Guo SK, et al. Structure and Degradation of Circular RNAs Regulate PKR Activation in Innate Immunity. Cell. 2019;177:865\u2013880.e21 Cell Press.","journal-title":"Cell"},{"key":"1187_CR13","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1080\/15476286.2015.1128065","volume":"13","author":"DB Dudekula","year":"2016","unstructured":"Dudekula DB, Panda AC, Grammatikakis I, De S, Abdelmohsen K, Gorospe M. Circinteractome: A web tool for exploring circular RNAs and their interacting proteins and microRNAs. RNA Biol. 2016;13:34\u201342 Taylor and Francis Inc.","journal-title":"RNA Biol"},{"key":"1187_CR14","doi-asserted-by":"crossref","unstructured":"Salzman J, Gawad C, Wang PL, Lacayo N, Brown PO. Circular RNAs are the predominant transcript isoform from hundreds of human genes in diverse cell types. PLoS One. 2012;7(2).","DOI":"10.1371\/journal.pone.0030733"},{"key":"1187_CR15","doi-asserted-by":"publisher","first-page":"4021","DOI":"10.1093\/nar\/gkw1201","volume":"45","author":"AC Panda","year":"2017","unstructured":"Panda AC, Grammatikakis I, Kim KM, De S, Martindale JL, Munk R, et al. Identification of senescence-associated circular RNAs (SAC-RNAs) reveals senescence suppressor CircPVT1. Nucleic Acids Res. 2017;45:4021\u201335 Oxford University Press.","journal-title":"Nucleic Acids Res"},{"key":"1187_CR16","doi-asserted-by":"publisher","first-page":"D308","DOI":"10.1093\/nar\/gkx1107","volume":"46","author":"S Fang","year":"2018","unstructured":"Fang S, Zhang L, Guo J, Niu Y, Wu Y, Li H, et al. NONCODEV5: a comprehensive annotation database for long non-coding RNAs. Nucleic Acids Res. 2018;46:D308\u201314 Oxford University Press.","journal-title":"Nucleic Acids Res"},{"key":"1187_CR17","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1089\/cbr.2018.2510","volume":"34","author":"M Salehi","year":"2019","unstructured":"Salehi M, Sharifi M, Bagheri M. Knockdown of Long Noncoding RNA Plasmacytoma Variant Translocation 1 with Antisense Locked Nucleic Acid GapmeRs Exerts Tumor-Suppressive Functions in Human Acute Erythroleukemia Cells Through Downregulation of C-MYC Expression. Cancer Biother Radiopharm. 2019;34:371\u20139 Mary Ann Liebert Inc.","journal-title":"Cancer Biother Radiopharm"},{"key":"1187_CR18","doi-asserted-by":"crossref","unstructured":"Schwarzer A, Emmrich S, Schmidt F, Beck D, Ng M, Reimer C, et al. The non-coding RNA landscape of human hematopoiesis and leukemia. Nat Commun Group. 2017;8(1):218 Nature Publishing.","DOI":"10.1038\/s41467-017-00212-4"},{"key":"1187_CR19","doi-asserted-by":"crossref","unstructured":"Verduci L, Ferraiuolo M, Sacconi A, Ganci F, Vitale J, Colombo T, et al. The oncogenic role of circPVT1 in head and neck squamous cell carcinoma is mediated through the mutant p53\/YAP\/TEAD transcription-competent complex. Genome Biol. 2017;18(1):237 BioMed Central Ltd.","DOI":"10.1186\/s13059-017-1368-y"},{"key":"1187_CR20","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.canlet.2016.12.006","volume":"388","author":"J Chen","year":"2017","unstructured":"Chen J, Li Y, Zheng Q, Bao C, He J, Chen B, et al. Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancer. Cancer Lett. 2017;388:208\u201319 Elsevier Ireland Ltd.","journal-title":"Cancer Lett"},{"key":"1187_CR21","doi-asserted-by":"crossref","unstructured":"Panda AC, De S, Grammatikakis I, Munk R, Yang X, Piao Y, et al. High-purity circular RNA isolation method (RPAD) reveals vast collection of intronic circRNAs. Nucleic Acids Res. 2017;45(12):e116 Oxford University Press.","DOI":"10.1093\/nar\/gkx297"},{"key":"1187_CR22","doi-asserted-by":"crossref","unstructured":"Tashiro K, Tseng Y-Y, Konety B, Bagchi A. Role of non-coding RNA PVT1 in regulating MYC in human cancer. J Urol. 2017;194.","DOI":"10.1016\/j.juro.2017.02.3104"},{"key":"1187_CR23","doi-asserted-by":"crossref","unstructured":"Derderian C, Orunmuyi AT, Oluwabunmi Olapade-Olaopa E, Ogunwobi OO. PVT1 signaling is a mediator of cancer progression. Front Oncol. 2019;9 Frontiers Media S.A.","DOI":"10.3389\/fonc.2019.00502"},{"key":"1187_CR24","doi-asserted-by":"crossref","unstructured":"Liu L, Wang J, Khanabdali R, Kalionis B, Tai X, Xia S. Circular RNAs: Isolation, characterization and their potential role in diseases. RNA Biol. 2017;14:1715\u201321 Taylor and Francis Inc.","DOI":"10.1080\/15476286.2017.1367886"},{"key":"1187_CR25","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1038\/ni.3771","volume":"18","author":"YG Chen","year":"2017","unstructured":"Chen YG, Satpathy AT, Chang HY. Gene regulation in the immune system by long noncoding RNAs. Nat Immunol. 2017;18:962\u201372.","journal-title":"Nat Immunol"},{"key":"1187_CR26","doi-asserted-by":"publisher","first-page":"848790","DOI":"10.1155\/2015\/848790","volume":"2015","author":"KR Sigdel","year":"2015","unstructured":"Sigdel KR, Cheng A, Wang Y, Duan L, Zhang Y. The emerging functions of long noncoding RNA in immune cells: autoimmune diseases. J Immunol Res. 2015;2015:848790.","journal-title":"J Immunol Res"},{"key":"1187_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0180922","volume":"12","author":"KR Gillinder","year":"2017","unstructured":"Gillinder KR, Tuckey H, Bell CC, Magor GW, Huang S, Ilsley MD, et al. Direct targets of pSTAT5 signalling in erythropoiesis. PLoS One. 2017;12:e0180922.","journal-title":"PLoS One"},{"key":"1187_CR28","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1667\/RR14891.1","volume":"189","author":"MJ Aryankalayil","year":"2018","unstructured":"Aryankalayil MJ, Chopra S, Levin J, Eke I, Makinde A, Das S, et al. Radiation-Induced Long Noncoding RNAs in a Mouse Model after Whole-Body Irradiation. Radiat Res. 2018;189:251 Radiation Research Society.","journal-title":"Radiat Res"},{"key":"1187_CR29","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1074\/jbc.M111.322875","volume":"287","author":"AM Barsotti","year":"2012","unstructured":"Barsotti AM, Beckerman R, Laptenko O, Huppi K, Caplen NJ, Prives C. p53-dependent induction of PVT1 and miR-1204. J Biol Chem. 2012;287:2509\u201319.","journal-title":"J Biol Chem"},{"key":"1187_CR30","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1038\/ng.3675","volume":"48","author":"PG Bronson","year":"2016","unstructured":"Bronson PG, Chang D, Bhangale T, Seldin MF, Ortmann W, Ferreira RC, et al. Common variants at PVT1, ATG13-AMBRA1, AHI1 and CLEC16A are associated with selective IgA deficiency. Nat Genet. 2016;48:1425\u20139.","journal-title":"Nat Genet"},{"key":"1187_CR31","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1073\/pnas.0307317101","volume":"101","author":"K Suzuki","year":"2004","unstructured":"Suzuki K, Meek B, Doi Y, Muramatsu M, Chiba T, Honjo T, et al. Aberrant expansion of segmented filamentous bacteria in IgA-deficient gut. Proc Natl Acad Sci U S A. 2004;101:1981\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1187_CR32","doi-asserted-by":"publisher","first-page":"19256","DOI":"10.1073\/pnas.0812681106","volume":"106","author":"Y Cong","year":"2009","unstructured":"Cong Y, Feng T, Fujihashi K, Schoeb TR, Elson CO. A dominant, coordinated T regulatory cell-IgA response to the intestinal microbiota. Proc Natl Acad Sci U S A. 2009;106:19256\u201361.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1187_CR33","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1007\/s10875-014-0009-4","volume":"34","author":"JF Ludvigsson","year":"2014","unstructured":"Ludvigsson JF, Neovius M, Hammarstr\u00f6m L. Association between IgA deficiency & other autoimmune conditions: a population-based matched cohort study. J Clin Immunol. 2014;34:444\u201351.","journal-title":"J Clin Immunol"},{"key":"1187_CR34","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.molcel.2013.12.025","volume":"53","author":"H Huang","year":"2014","unstructured":"Huang H, Zeqiraj E, Dong B, Jha BK, Duffy NM, Orlicky S, et al. Dimeric structure of pseudokinase RNase L bound to 2-5A reveals a basis for interferon-induced antiviral activity. Mol Cell. 2014;53:221\u201334.","journal-title":"Mol Cell"},{"key":"1187_CR35","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s12031-017-0982-1","volume":"63","author":"MM Eftekharian","year":"2017","unstructured":"Eftekharian MM, Ghafouri-Fard S, Soudyab M, Omrani MD, Rahimi M, Sayad A, et al. Expression analysis of long non-coding RNAs in the blood of multiple sclerosis patients. J Mol Neurosci. 2017;63:333\u201341 Springer New York LLC.","journal-title":"J Mol Neurosci"},{"key":"1187_CR36","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1093\/abbs\/gmx048","volume":"49","author":"X Yu","year":"2017","unstructured":"Yu X, Zhe Z, Tang B, Li S, Tang L, Wu Y, et al. \u03b1-Asarone suppresses the proliferation and migration of ASMCs through targeting the lncRNA-PVT1\/miR-203a\/E2F3 signal pathway in RSV-infected rats. Acta Biochim Biophys Sin (Shanghai). 2017;49:598\u2013608.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"1187_CR37","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.intimp.2017.03.030","volume":"47","author":"W Huang","year":"2017","unstructured":"Huang W, Lan X, Li X, Wang D, Sun Y, Wang Q, et al. Long non-coding RNA PVT1 promote LPS-induced septic acute kidney injury by regulating TNF\u03b1 and JNK\/NF-\u03baB pathways in HK-2 cells. Int Immunopharmacol. 2017;47:134\u201340.","journal-title":"Int Immunopharmacol"},{"key":"1187_CR38","doi-asserted-by":"crossref","unstructured":"Zheng Y, Tian X, Wang T, Xia X, Cao F, Tian J, et al. Long noncoding RNA Pvt1 regulates the immunosuppression activity of granulocytic myeloid-derived suppressor cells in tumor-bearing mice. Mol Cancer. 2019;18(1):61 BioMed Central Ltd.","DOI":"10.1186\/s12943-019-0978-2"},{"key":"1187_CR39","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/0145-2126(88)90120-8","volume":"12","author":"C Asker","year":"1988","unstructured":"Asker C, Mareni C, Coviello D, Ingvarsson S, Sessarego M, Origone P, et al. Amplification of c-myc and pvt-1 homologous sequences in acute nonlymphatic leukemia. Leuk Res. 1988;12:523\u20137.","journal-title":"Leuk Res"},{"key":"1187_CR40","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1093\/hmg\/ddh164","volume":"13","author":"CT Storlazzi","year":"2004","unstructured":"Storlazzi CT, Fioretos T, Paulsson K, Str\u00f6mbeck B, Lassen C, Ahlgren T, et al. Identification of a commonly amplified 4.3 Mb region with overexpression of C8FW, but not MYC in MYC-containing double minutes in myeloid malignancies. Hum Mol Genet. 2004;13:1479\u201385.","journal-title":"Hum Mol Genet"},{"key":"1187_CR41","doi-asserted-by":"crossref","unstructured":"L\u2019Abbate A, Tolomeo D, Cifola I, Severgnini M, Turchiano A, Augello B, et al. MYC-containing amplicons in acute myeloid leukemia: genomic structures, evolution, and transcriptional consequences. Leukemia. 2018:32(10):2304.","DOI":"10.1038\/s41375-018-0177-y"},{"key":"1187_CR42","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13045-014-0068-2","volume":"7","author":"Y Chinen","year":"2014","unstructured":"Chinen Y, Sakamoto N, Nagoshi H, Taki T, Maegawa S, Tatekawa S, et al. 8q24 amplified segments involve novel fusion genes between NSMCE2 and long noncoding RNAs in acute myelogenous leukemia. J Hematol Oncol. 2014;7:68.","journal-title":"J Hematol Oncol"},{"key":"1187_CR43","doi-asserted-by":"crossref","unstructured":"El-Khazragy N, Elayat W, Matbouly S, Seliman S, Sami A, Safwat G, et al. The prognostic significance of the long non-coding RNAs \u201cCCAT1, PVT1\u201d in t (8;21) associated acute myeloid leukemia. Gene. 2019;707:172\u201377.","DOI":"10.1016\/j.gene.2019.03.055"},{"key":"1187_CR44","doi-asserted-by":"crossref","unstructured":"Del\u00e1s MJ, Sabin LR, Dolzhenko E, Knott SR, Munera Maravilla E, Jackson BT, et al. lncRNA requirements for mouse acute myeloid leukemia and normal differentiation. Elife. 2017;6.","DOI":"10.7554\/eLife.25607"},{"key":"1187_CR45","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1089\/gtmb.2018.0143","volume":"22","author":"M Izadifard","year":"2018","unstructured":"Izadifard M, Pashaiefar H, Yaghmaie M, Montazeri M, Sadraie M, Momeny M, et al. Expression analysis of PVT1, CCDC26, and CCAT1 long noncoding RNAs in acute myeloid leukemia patients. Genet Test Mol Biomarkers. 2018;22:593\u20138 Mary Ann Liebert Inc.","journal-title":"Genet Test Mol Biomarkers"},{"key":"1187_CR46","doi-asserted-by":"crossref","unstructured":"Zeng C, Yu X, Lai J, Yang L, Chen S, Li Y. Overexpression of the long non-coding RNA PVT1 is correlated with leukemic cell proliferation in acute promyelocytic leukemia. J Hematol Oncol. 2015;8:126 BioMed Central Ltd.","DOI":"10.1186\/s13045-015-0223-4"},{"key":"1187_CR47","doi-asserted-by":"crossref","unstructured":"G\u00f3mez-Segu\u00ed I, S\u00e1nchez-Izquierdo D, Barrag\u00e1n E, Such E, Luna I, L\u00f3pez-Pav\u00eda M, et al. Single-nucleotide polymorphism array-based karyotyping of acute promyelocytic leukemia. PLoS One. 2014;9(6). Public Library of Science.","DOI":"10.1371\/journal.pone.0100245"},{"key":"1187_CR48","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.biocel.2018.03.001","volume":"98","author":"M Houshmand","year":"2018","unstructured":"Houshmand M, Yazdi N, Kazemi A, Atashi A, Hamidieh AA, Anjam Najemdini A, et al. Long non-coding RNA PVT1 as a novel candidate for targeted therapy in hematologic malignancies. Int J Biochem Cell Biol. 2018;98:54\u201364 Elsevier Ltd.","journal-title":"Int J Biochem Cell Biol"},{"key":"1187_CR49","unstructured":"Salehi M, Sharifi M. Induction of apoptosis and necrosis in human acute erythroleukemia cells by inhibition of 47Tlong non-coding RNA PVT1. Mol Biol Res Commun. 2018;7(2):89\u201396."},{"key":"1187_CR50","doi-asserted-by":"publisher","first-page":"723","DOI":"10.2217\/epi-2017-0142","volume":"10","author":"J Hu","year":"2018","unstructured":"Hu J, Han Q, Gu Y, Ma J, McGrath M, Qiao F, et al. Circular RNA PVT1 expression and its roles in acute lymphoblastic leukemia. Epigenomics. 2018;10:723\u201332 Future Medicine Ltd.","journal-title":"Epigenomics"},{"key":"1187_CR51","doi-asserted-by":"crossref","unstructured":"Gaffo E, Boldrin E, Dal Molin A, Bresolin S, Bonizzato A, Trentin L, et al. Circular RNA differential expression in blood cell populations and exploration of circRNA deregulation in pediatric acute lymphoblastic leukemia. Sci Rep. 2019;9(1):14670.","DOI":"10.1038\/s41598-019-50864-z"},{"key":"1187_CR52","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3906\/biy-1801-46","volume":"42","author":"N Yazdi","year":"2018","unstructured":"Yazdi N, Houshmand M, Atashi A, Kazemi A, Najmedini AA, Zarif MN. Long noncoding RNA PVT1: potential oncogene in the development of acute lymphoblastic leukemia. Turkish J Biol. 2018;42:405\u201313 Scientific and Technical Research Council of Turkey.","journal-title":"Turkish J Biol"},{"key":"1187_CR53","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/bjh.13482","volume":"172","author":"G Macchia","year":"2016","unstructured":"Macchia G, Lonoce A, Venuto S, Macr\u00ed E, Palumbo O, Carella M, et al. A rare but recurrent t (8;13)(q24;q14) translocation in B-cell chronic lymphocytic leukaemia causing MYC up-regulation and concomitant loss of PVT1, miR-15\/16 and DLEU7. Br J Haematol. 2016;172:296\u20139 Blackwell Publishing Ltd.","journal-title":"Br J Haematol"},{"key":"1187_CR54","doi-asserted-by":"publisher","first-page":"4037","DOI":"10.1093\/nar\/14.10.4037","volume":"14","author":"LK Sun","year":"1986","unstructured":"Sun LK, Showe LC, Croce CM. Analysis of the 3\u2032 flanking region of the human c-myc gene in lymphomas with the t (8;22) and t (2;8) chromosomal translocations. Nucleic Acids Res. 1986;14:4037\u201350.","journal-title":"Nucleic Acids Res"},{"key":"1187_CR55","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1128\/MCB.9.5.2105","volume":"9","author":"B Henglein","year":"1989","unstructured":"Henglein B, Synovzik H, Groitl P, Bornkamm GW, Hartl P, Lipp M. Three breakpoints of variant t (2;8) translocations in Burkitt\u2019s lymphoma cells fall within a region 140 kilobases distal from c-myc. Mol Cell Biol. 1989;9:2105\u201313 American Society for Microbiology.","journal-title":"Mol Cell Biol"},{"key":"1187_CR56","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/(SICI)1098-2264(199811)23:3<220::AID-GCC3>3.0.CO;2-3","volume":"23","author":"KA Rack","year":"1998","unstructured":"Rack KA, Delabesse E, Radford-Weiss I, Bourquelot P, Le Guyader G, Vekemans M, et al. Simultaneous detection of MYC, BVR1, and PVT1 translocations in lymphoid malignancies by fluorescence in situ hybridization. Genes Chromosomes Cancer. 1998;23:220\u20136.","journal-title":"Genes Chromosomes Cancer"},{"key":"1187_CR57","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1182\/blood-2017-01-757542","volume":"130","author":"BM Grande","year":"2017","unstructured":"Grande BM, Gerhard DS, Griner NB, Casper C, Namirembe C, Omoding A, et al. Burkitt lymphoma genome sequencing project (BLGSP): integrative genomic and Transcriptomic characterization of Burkitt lymphoma. Blood. 2017;130:39.","journal-title":"Blood"},{"key":"1187_CR58","first-page":"1225","volume":"18","author":"C Zheng","year":"2019","unstructured":"Zheng C, Xiao Y, Li Y, He D. Knockdown of long non-coding RNA PVT1 inhibits the proliferation of raji cells through cell cycle regulation. Oncol Lett. 2019;18:1225\u201334 Spandidos Publications.","journal-title":"Oncol Lett"},{"key":"1187_CR59","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1038\/ng.696","volume":"42","author":"V Enciso-Mora","year":"2010","unstructured":"Enciso-Mora V, Broderick P, Ma Y, Jarrett RF, Hjalgrim H, Hemminki K, et al. A genome-wide association study of Hodgkin\u2019s lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3). Nat Genet. 2010;42:1126\u201330.","journal-title":"Nat Genet"},{"key":"1187_CR60","doi-asserted-by":"crossref","unstructured":"Ghesqui\u00e8res H, Larrabee BR, Casasnovas O, Maurer MJ, McKay JD, Ansell SM, et al. A susceptibility locus for classical Hodgkin lymphoma at 8q24 near MYC\/PVT1 predicts patient outcome in two independent cohorts. Br J Haematol. 2018;180:286\u201390. Blackwell Publishing Ltd.","DOI":"10.1111\/bjh.14306"},{"key":"1187_CR61","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1038\/ng.3105","volume":"46","author":"JR Cerhan","year":"2014","unstructured":"Cerhan JR, Berndt SI, Vijai J, Ghesqui\u00e8res H, McKay J, Wang SS, et al. Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma. Nat Genet. 2014;46:1233\u20138 Nature Publishing Group.","journal-title":"Nat Genet"},{"key":"1187_CR62","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/ejh.12513","volume":"95","author":"BA Bassig","year":"2015","unstructured":"Bassig BA, Cerhan JR, Au WY, Kim HN, Sangrajrang S, Hu W, et al. Genetic susceptibility to diffuse large B-cell lymphoma in a pooled study of three eastern Asian populations. Eur J Haematol. 2015;95:442\u20138 Blackwell Publishing Ltd.","journal-title":"Eur J Haematol"},{"key":"1187_CR63","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1182\/blood.2019002600","volume":"134","author":"LK Hilton","year":"2019","unstructured":"Hilton LK, Tang J, Ben-Neriah S, Alcaide M, Jiang A, Grande BM, et al. The double-hit signature identifies double-hit diffuse large B-cell lymphoma with genetic events cryptic to FISH. Blood. 2019;134:1528\u201332 American Society of Hematology.","journal-title":"Blood"},{"key":"1187_CR64","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1002\/2211-5463.12538","volume":"8","author":"S Mizuno","year":"2018","unstructured":"Mizuno S, Hanamura I, Ota A, Karnan S, Kanasugi J, Nakamura A, et al. Establishment and characterization of a novel vincristine-resistant diffuse large B-cell lymphoma cell line containing the 8q24 homogeneously staining region. FEBS Open Bio. 2018;8:1977\u201391 Wiley Blackwell.","journal-title":"FEBS Open Bio"},{"key":"1187_CR65","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.ajhg.2014.09.004","volume":"95","author":"CF Skibola","year":"2014","unstructured":"Skibola CF, Berndt SI, Vijai J, Conde L, Wang Z, Yeager M, et al. Genome-wide association study identifies five susceptibility loci for follicular lymphoma outside the HLA region. Am J Hum Genet. 2014;95:462\u201371 Cell Press.","journal-title":"Am J Hum Genet"},{"key":"1187_CR66","doi-asserted-by":"publisher","first-page":"4954","DOI":"10.1158\/0008-5472.CAN-12-0213","volume":"72","author":"H Nagoshi","year":"2012","unstructured":"Nagoshi H, Taki T, Hanamura I, Nitta M, Otsuki T, Nishida K, et al. Frequent PVT1 rearrangement and novel chimeric genes PVT1-NBEA and PVT1-WWOX occur in multiple myeloma with 8q24 abnormality. Cancer Res. 2012;72:4954\u201362.","journal-title":"Cancer Res"},{"key":"1187_CR67","first-page":"1359","volume":"5","author":"MH Bakkus","year":"1990","unstructured":"Bakkus MH, Brakel-van Peer KM, Michiels JJ, van\u2019t Veer MB, Benner R. Amplification of the c-myc and the pvt-like region in human multiple myeloma. Oncogene. 1990;5:1359\u201364.","journal-title":"Oncogene"},{"key":"1187_CR68","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.5114\/aoms.2018.73975","volume":"14","author":"M Yang","year":"2018","unstructured":"Yang M, Zhang L, Wang X, Zhou Y, Wu S. Down-regulation of miR-203a by lncRNA PVT1 in multiple myeloma promotes cell proliferation. Arch Med Sci. 2018;14:1333\u20139 Termedia Publishing House Ltd.","journal-title":"Arch Med Sci"},{"key":"1187_CR69","doi-asserted-by":"crossref","unstructured":"Mikulasova A, Ashby C, Tytarenko RG, Qu P, Rosenthal A, Dent JA, et al. Microhomology-mediated end joining drives complex rearrangements and over expression of MYC and PVT1 in multiple myeloma. Haematologica. 2019; haematol.2019.217927. Ferrata Storti Foundation (Haematologica).","DOI":"10.3324\/haematol.2019.217927"},{"key":"1187_CR70","first-page":"3085","volume":"130","author":"X-Y Wan","year":"2017","unstructured":"Wan X-Y, Chu Z-B, Hu Y, Sun C-Y, Zou J. CircPVT1 inhibit apoptosis and enhance drug resistance in multiple myeloma. Blood. 2017;130:3085.","journal-title":"Blood"},{"key":"1187_CR71","doi-asserted-by":"crossref","unstructured":"Akagi K. RTCGD: retroviral tagged cancer gene database. Nucleic Acids Res. 2004;32:523D\u20135527. Oxford University Press (OUP).","DOI":"10.1093\/nar\/gkh013"},{"key":"1187_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2015.26","volume":"5","author":"Y Nakamura","year":"2015","unstructured":"Nakamura Y, Kayano H, Kakegawa E, Miyazaki H, Nagai T, Uchida Y, et al. Identification of SUPT3H as a novel 8q24\/MYC partner in blastic plasmacytoid dendritic cell neoplasm with t (6;8)(p21;q24) translocation. Blood Cancer J. 2015;5:e301.","journal-title":"Blood Cancer J"},{"key":"1187_CR73","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1159\/000488627","volume":"46","author":"RQ He","year":"2018","unstructured":"He RQ, Qin MJ, Lin P, Luo YH, Ma J, Yang H, et al. Prognostic significance of LncRNA PVT1 and its potential target gene network in human cancers: a comprehensive inquiry based upon 21 Cancer types and 9972 cases. Cell Physiol Biochem. 2018;46:591\u2013608 S Karger AG.","journal-title":"Cell Physiol Biochem"},{"key":"1187_CR74","first-page":"3799","volume":"130","author":"X Ma","year":"2017","unstructured":"Ma X, Jin W, Zhao M, Zhang W, Li J, Wang K. Long noncoding RNA profiling reveals an abundant Crnde that inhibits granulocytic differentiation in APL. Blood. 2017;130:3799.","journal-title":"Blood"},{"key":"1187_CR75","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1177\/1724600818777242","volume":"33","author":"H Fan","year":"2018","unstructured":"Fan H, Zhu JH, Yao XQ. Long non-coding RNA PVT1 as a novel potential biomarker for predicting the prognosis of colorectal cancer. Int J Biol Markers. 2018;33:415\u201322 SAGE Publications Ltd.","journal-title":"Int J Biol Markers"},{"key":"1187_CR76","doi-asserted-by":"crossref","unstructured":"Zuber J, Shi J, Wang E, Rappaport AR, Herrmann H, Sison EA, et al. RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia. Nature. 2011;478(7370):524\u20138.","DOI":"10.1038\/nature10334"},{"key":"1187_CR77","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature11993","volume":"495","author":"TB Hansen","year":"2013","unstructured":"Hansen TB, Jensen TI, Clausen BH, Bramsen JB, Finsen B, Damgaard CK, et al. Natural RNA circles function as efficient microRNA sponges. Nature. 2013;495:384\u20138.","journal-title":"Nature"},{"key":"1187_CR78","doi-asserted-by":"publisher","first-page":"3791","DOI":"10.1158\/1078-0432.CCR-11-2342","volume":"18","author":"JR Brown","year":"2012","unstructured":"Brown JR, Hanna M, Tesar B, Werner L, Pochet N, Asara JM, et al. Integrative genomic analysis implicates gain of PIK3CA at 3q26 and MYC at 8q24 in chronic lymphocytic leukemia. Clin Cancer Res. 2012;18:3791\u2013802.","journal-title":"Clin Cancer Res"},{"key":"1187_CR79","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/modpathol.2016.35","volume":"29","author":"Y Li","year":"2016","unstructured":"Li Y, Hu S, Wang SA, Li S, Huh YO, Tang Z, et al. The clinical significance of 8q24\/MYC rearrangement in chronic lymphocytic leukemia. Mod Pathol. 2016;29:444\u201351 Nature Publishing Group.","journal-title":"Mod Pathol"},{"key":"1187_CR80","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1111\/j.1365-2141.2011.08789.x","volume":"154","author":"A Rinaldi","year":"2011","unstructured":"Rinaldi A, Mian M, Kwee I, Rossi D, Deambrogi C, Mensah AA, et al. Genome-wide DNA profiling better defines the prognosis of chronic lymphocytic leukaemia. Br J Haematol. 2011;154:590\u20139.","journal-title":"Br J Haematol"},{"key":"1187_CR81","doi-asserted-by":"publisher","first-page":"920","DOI":"10.3109\/10428194.2013.845882","volume":"55","author":"J Houldsworth","year":"2014","unstructured":"Houldsworth J, Guttapalli A, Thodima V, Yan XJ, Mendiratta G, Zielonka T, et al. Genomic imbalance defines three prognostic groups for risk stratification of patients with chronic lymphocytic leukemia. Leuk Lymphoma. 2014;55:920\u20138 Informa Healthcare.","journal-title":"Leuk Lymphoma"},{"key":"1187_CR82","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/ajh.24990","volume":"93","author":"E Chapiro","year":"2018","unstructured":"Chapiro E, Lesty C, Gabillaud C, Durot E, Bouzy S, Armand M, et al. \u201cDouble-hit\u201d chronic lymphocytic leukemia: An aggressive subgroup with 17p deletion and 8q24 gain. Am J Hematol. 2018;93:375\u201382 Wiley-Liss Inc.","journal-title":"Am J Hematol"},{"key":"1187_CR83","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/314740a0","volume":"314","author":"M Graham","year":"1985","unstructured":"Graham M, Adams JM, Cory S. Murine T lymphomas with retroviral inserts in the chromosomal 15 locus for plasmacytoma variant translocations. Nature. 1985;314:740\u20133.","journal-title":"Nature"},{"key":"1187_CR84","doi-asserted-by":"crossref","unstructured":"Beck-Engeser GB, Lum AM, Huppi K, Caplen NJ, Wang BB, Wabl M. Pvt1-encoded microRNAs in oncogenesis. Retrovirology. 2008:5;4.","DOI":"10.1186\/1742-4690-5-4"},{"key":"1187_CR85","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1073\/pnas.81.1.38","volume":"81","author":"G Lemay","year":"1984","unstructured":"Lemay G, Jolicoeur P. Rearrangement of a DNA sequence homologous to a cell virus junction fragment in several Moloney murine leukemia virus induced rat thymomas. Proc Natl Acad Sci U S A. 1984;81:38\u201342.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1187_CR86","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1128\/MCB.6.5.1834","volume":"6","author":"L Villeneuve","year":"1986","unstructured":"Villeneuve L, Rassart E, Jolicoeur P, Graham M, Adams JM. Proviral integration site Mis-1 in rat thymomas corresponds to the pvt-1 translocation breakpoint in murine plasmacytomas. Mol Cell Biol. 1986;6:1834\u20137 American Society for Microbiology.","journal-title":"Mol Cell Biol"},{"key":"1187_CR87","first-page":"20565","volume":"8","author":"E Liu","year":"2015","unstructured":"Liu E, Liu Z, Zhou Y, Mi R, Wang D. Overexpression of long non-coding RNA PVT1 in ovarian cancer cells promotes cisplatin resistance by regulating apoptotic pathways. Int J Clin Exp Med. 2015;8:20565\u201372 E-Century Publishing Corporation.","journal-title":"Int J Clin Exp Med"},{"key":"1187_CR88","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1002\/ijc.2910590623","volume":"59","author":"K Huppi","year":"1994","unstructured":"Huppi K, Siwarski D. Chimeric transcripts with an open reading frame are generated as a result of translocation to the Pvt-1 region in mouse B-cell tumors. Int J Cancer. 1994;59:848\u201351.","journal-title":"Int J Cancer"},{"key":"1187_CR89","doi-asserted-by":"crossref","unstructured":"McNeil N, Joong SK, Ried T, Janz S. Extraosseous IL-6 transgenic mouse plasmacytoma sometimes lacks Myc-activating chromosomal translocation. Genes Chromosom Cancer. 2005;43(2):137\u201346.","DOI":"10.1002\/gcc.20172"},{"key":"1187_CR90","doi-asserted-by":"publisher","first-page":"6964","DOI":"10.1073\/pnas.87.18.6964","volume":"87","author":"K Huppi","year":"1990","unstructured":"Huppi K, Siwarski D, Skurla R, Klinman D, Mushinski JF. Pvt-1 transcripts are found in normal tissues and are altered by reciprocal (6;15) translocations in mouse plasmacytomas. Proc Natl Acad Sci U S A. 1990;87:6964\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1187_CR91","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1002\/jcp.21133","volume":"213","author":"L Carramusa","year":"2007","unstructured":"Carramusa L, Contino F, Ferro A, Minafra L, Perconti G, Giallongo A, et al. The PVT-1 oncogene is a Myc protein target that is overexpressed in transformed cells. J Cell Physiol. 2007;213:511\u20138.","journal-title":"J Cell Physiol"},{"key":"1187_CR92","first-page":"4397","volume":"130","author":"K Homma","year":"2017","unstructured":"Homma K, Oda T, Murakami YG, Watanabe S, Ishihara R, Kuroda Y, et al. Long noncoding RNA PVT1 and MYC are co-regulated by Bromodomain protein BRD4 in multiple myeloma and associated with disease Progressionn. Blood. 2017;130:4397.","journal-title":"Blood"},{"key":"1187_CR93","doi-asserted-by":"crossref","unstructured":"Colombo T, Farina L, Macino G, Paci P. PVT1: a rising star among oncogenic long noncoding RNAs. Biomed Res Int. 2015. Hindawi Publishing Corporation.","DOI":"10.1155\/2015\/304208"},{"key":"1187_CR94","doi-asserted-by":"publisher","first-page":"W130","DOI":"10.1093\/nar\/gkx356","volume":"45","author":"J Wang","year":"2017","unstructured":"Wang J, Vasaikar S, Shi Z, Greer M, Zhang B. WebGestalt 2017: a more comprehensive, powerful, flexible and interactive gene set enrichment analysis toolkit. Nucleic Acids Res. 2017;45:W130\u20137 Oxford University Press.","journal-title":"Nucleic Acids Res"},{"key":"1187_CR95","doi-asserted-by":"crossref","unstructured":"Jin K, Wang S, Zhang Y, Xia M, Mo Y, Li X, et al. Long non-coding RNA PVT1 interacts with MYC and its downstream molecules to synergistically promote tumorigenesis. Cell Mol Life Sci. 2019;76:4275\u201389 Birkhauser Verlag AG.","DOI":"10.1007\/s00018-019-03222-1"},{"key":"1187_CR96","doi-asserted-by":"crossref","unstructured":"Adhikary J, Chakraborty S, Dalal S, Basu S, Dey A, Ghosh A. Circular PVT1: an oncogenic non-coding RNA with emerging clinical importance. J Clin Pathol. 2019;72(8):513\u20139.","DOI":"10.1136\/jclinpath-2019-205891"},{"key":"1187_CR97","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/nature13311","volume":"512","author":"YY Tseng","year":"2014","unstructured":"Tseng YY, Moriarity BS, Gong W, Akiyama R, Tiwari A, Kawakami H, et al. PVT1 dependence in cancer with MYC copy-number increase. Nature. 2014;512:82\u20136 Nature Publishing Group.","journal-title":"Nature"},{"key":"1187_CR98","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov MV, Jones MR, Rouillard AD, Fernandez NF, Duan Q, Wang Z, et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 2016;44:W90\u20137.","journal-title":"Nucleic Acids Res"},{"key":"1187_CR99","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1007\/s13277-015-4149-9","volume":"37","author":"Q Zhou","year":"2016","unstructured":"Zhou Q, Chen J, Feng J, Wang J. Long noncoding RNA PVT1 modulates thyroid cancer cell proliferation by recruiting EZH2 and regulating thyroid-stimulating hormone receptor (TSHR). Tumor Biol. 2016;37:3105\u201313 Springer Netherlands.","journal-title":"Tumor Biol"},{"key":"1187_CR100","doi-asserted-by":"crossref","unstructured":"Wan L, Sun M, Liu GJ, Wei CC, Zhang EB, Kong R, et al. Long noncoding RNA PVT1 promotes non-small cell lung cancer cell proliferation through epigenetically regulating LATS2 expression. Mol Cancer Ther. 2016;15(5):1082\u201394.","DOI":"10.1158\/1535-7163.MCT-15-0707"},{"key":"1187_CR101","doi-asserted-by":"crossref","unstructured":"Kong R, Zhang EB, Yin DD, You LH, Xu TP, Chen WM, et al. Long noncoding RNA PVT1 indicates a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically regulating p15 and p16. Mol Cancer. 2015;14:82. BioMed Central Ltd.","DOI":"10.1186\/s12943-015-0355-8"},{"key":"1187_CR102","doi-asserted-by":"crossref","unstructured":"Nakagawa M, Kitabayashi I. Oncogenic roles of enhancer of zeste homolog 1\/2 in hematological malignancies. Cancer Sci, Blackwell Publishing Ltd. 2018;109:2342\u20138.","DOI":"10.1111\/cas.13655"},{"key":"1187_CR103","doi-asserted-by":"crossref","unstructured":"Peveling-Oberhag J, Crisman G, Schmidt A, D\u00f6ring C, Lucioni M, Arcaini L, et al. Dysregulation of global microRNA expression in splenic marginal zone lymphoma and influence of chronic hepatitis C virus infection. Leukemia. 2012;26(7):1654\u201362.","DOI":"10.1038\/leu.2012.29"},{"key":"1187_CR104","doi-asserted-by":"crossref","unstructured":"Kasama Y, Mizukami T, Kusunoki H, Peveling-Oberhag J, Nishito Y, Ozawa M, et al. B-cell-intrinsic hepatitis C virus expression leads to B-cell- lymphomagenesis and induction of NF-\u03baB signalling. PLoS One. 2014;9(3).","DOI":"10.1371\/journal.pone.0091373"},{"key":"1187_CR105","doi-asserted-by":"crossref","unstructured":"Lim EL, Trinh DL, Scott DW, Chu A, Krzywinski M, Zhao Y, et al. Comprehensive miRNA sequence analysis reveals survival differences in diffuse large B-cell lymphoma patients. Genome Biol. 2015;16:18.","DOI":"10.1186\/s13059-014-0568-y"},{"key":"1187_CR106","doi-asserted-by":"crossref","unstructured":"Arribas AJ, G\u00f3mez-Abad C, S\u00e1nchez-Beato M, Martinez N, Dilisio L, Casado F, et al. Splenic marginal zone lymphoma: comprehensive analysis of gene expression and miRNA profiling. Mod Pathol. 2013:26(7):889\u2013901.","DOI":"10.1038\/modpathol.2012.220"},{"key":"1187_CR107","doi-asserted-by":"crossref","unstructured":"Zhu Q, Li Y, Guo Y, Hu L, Xiao Z, Liu X, et al. Long non-coding RNA SNHG16 promotes proliferation and inhibits apoptosis of diffuse large B-cell lymphoma cells by targeting miR-497-5p\/PIM1 axis. J Cell Mol Med. 2019;23(11):7395\u2013405.","DOI":"10.1111\/jcmm.14601"},{"key":"1187_CR108","doi-asserted-by":"crossref","unstructured":"Troppan K, Wenzl K, Pichler M, Pursche B, Schwarzenbacher D, Feichtinger J, et al. miR-199a and miR-497 are associated with better overall survival due to increased chemosensitivity in diffuse large b-cell lymphoma patients. Int J Mol Sci. 2015;16(8):18077\u201395.","DOI":"10.3390\/ijms160818077"},{"key":"1187_CR109","doi-asserted-by":"crossref","unstructured":"Jia CM, Tian YY, Quan LN, Jiang L, Liu AC. miR-26b-5p suppresses proliferation and promotes apoptosis in multiple myeloma cells by targeting JAG1. Pathol Res Pract. 2018;214(9):1388\u201394.","DOI":"10.1016\/j.prp.2018.07.025"},{"key":"1187_CR110","unstructured":"Fan F, Deng R, Qiu L, Wen Q, Zeng Y, Gao L, et al. miR-203a-3p.1 is involved in the regulation of osteogenic differentiation by directly targeting Smad9 in MM-MSCs. Oncol Lett. 2019;18(6):6339\u201346."},{"key":"1187_CR111","doi-asserted-by":"publisher","first-page":"640","DOI":"10.3324\/haematol.2012.070011","volume":"98","author":"I Misiewicz-Krzeminska","year":"2013","unstructured":"Misiewicz-Krzeminska I, Sarasquete ME, Quwaider D, Krzeminski P, Ticona FV, Pa\u00edno T, et al. Restoration of microRNA-214 expression reduces growth of myeloma cells through positive regulation of P53 and inhibition of DNA replication. Haematologica. 2013;98:640\u20138.","journal-title":"Haematologica"},{"key":"1187_CR112","doi-asserted-by":"crossref","unstructured":"Tian F, Zhan Y, Zhu W, Li J, Tang M, Chen X, et al. MicroRNA-497 inhibits multiple myeloma growth and increases susceptibility to bortezomib by targeting Bcl-2. Int J Mol Med. 2019;43(2):1058\u201366.","DOI":"10.3892\/ijmm.2019.4297"},{"key":"1187_CR113","unstructured":"Yu T, Zhang X, Zhang L, Wang Y, Pan H, Xu Z, et al. MicroRNA-497 suppresses cell proliferation and induces apoptosis through targeting PBX3 in human multiple myeloma. Am J Cancer Res. 2016;6(12):2880\u20139."},{"key":"1187_CR114","doi-asserted-by":"crossref","unstructured":"Yuan T, Yang Y, Chen J, Li W, Li W, Zhang Q, et al. Regulation of PI3K signaling in T-cell acute lymphoblastic leukemia: a novel PTEN\/Ikaros\/miR-26b mechanism reveals a critical targetable role for PIK3CD. Leukemia. 2017;31(11):2355\u201364.","DOI":"10.1038\/leu.2017.80"},{"key":"1187_CR115","doi-asserted-by":"crossref","unstructured":"He Z, Liao Z, Chen S, Li B, Yu Z, Luo G, et al. Downregulated miR-17, miR-29c, miR-92a and miR-214 may be related to BCL11B overexpression in T cell acute lymphoblastic leukemia. Asia Pac J Clin Oncol. 2018;14(5):e259\u2013e265.","DOI":"10.1111\/ajco.12979"},{"key":"1187_CR116","doi-asserted-by":"crossref","unstructured":"Fan FY, Deng R, Yi H, Sun HP, Zeng Y, He GC, et al. The inhibitory effect of MEG3\/miR-214\/AIFM2 axis on the growth of T-cell lymphoblastic lymphoma. Int J Oncol. 2017;51(1):316\u201326.","DOI":"10.3892\/ijo.2017.4006"},{"key":"1187_CR117","doi-asserted-by":"crossref","unstructured":"Zou ZJ, Fan L, Wang L, Xu J, Zhang R, Tian T, et al. miR-26a and miR-214 down-regulate expression of the PTEN gene in chronic lymphocytic leukemia, but not PTEN mutation or promoter methylation. Oncotarget. 2015;6(2):1276\u201385.","DOI":"10.18632\/oncotarget.2626"},{"key":"1187_CR118","doi-asserted-by":"crossref","unstructured":"Pallasch CP, Patz M, Yoon JP, Hagist S, Eggle D, Claus R, et al. miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia. Blood. 2009;114(15):3255\u201364.","DOI":"10.1182\/blood-2009-06-229898"},{"key":"1187_CR119","doi-asserted-by":"crossref","unstructured":"Forrest ARR, Kanamori-Katayama M, Tomaru Y, Lassmann T, Ninomiya N, Takahashi Y, et al. Induction of microRNAs, mir-155, mir-222, mir-424 and mir-503, promotes monocytic differentiation through combinatorial regulation. Leukemia. 2010;24(2):460\u20136.","DOI":"10.1038\/leu.2009.246"},{"key":"1187_CR120","doi-asserted-by":"crossref","unstructured":"Maura F, Cutrona G, Mosca L, Matis S, Lionetti M, Fabris S, et al. Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemia. Leuk Lymphoma. 2015;56(11):3150\u20138.","DOI":"10.3109\/10428194.2015.1028051"},{"key":"1187_CR121","doi-asserted-by":"crossref","unstructured":"Lionetti M, Musto P, Di MMT, Fabris S, Agnelli L, Todoerti K, et al. Biological and clinical relevance of miRNA expression signatures in primary plasma cell leukemia. Clin Cancer Res. 2013;19(12):3130\u201342.","DOI":"10.1158\/1078-0432.CCR-12-2043"},{"key":"1187_CR122","doi-asserted-by":"crossref","unstructured":"Wang W, Zhou R, Wu Y, Liu Y, Su W, Xiong W, et al. PVT1 promotes cancer progression via MicroRNAs. Front Oncol. 2019:9;609. Frontiers Media SA.","DOI":"10.3389\/fonc.2019.00609"},{"key":"1187_CR123","doi-asserted-by":"crossref","unstructured":"Ma Y, Wang P, Xue Y, Qu C, Zheng J, Liu X, et al. PVT1 affects growth of glioma microvascular endothelial cells by negatively regulating miR-186. Tumor Biol. 2017;39(3). SAGE Publications Ltd.","DOI":"10.1177\/1010428317694326"},{"key":"1187_CR124","first-page":"489","volume":"42","author":"J Zheng","year":"2018","unstructured":"Zheng J, Hu L, Cheng J, Xu J, Zhong Z, Yang Y, et al. LncRNA PVT1 promotes the angiogenesis of vascular endothelial cell by targeting miR-26b to activate CTGF\/ANGPT2. Int J Mol Med. 2018;42:489\u201396 Spandidos Publications.","journal-title":"Int J Mol Med"},{"key":"1187_CR125","doi-asserted-by":"crossref","unstructured":"Zhao J, Du P, Cui P, Qin Y, Hu C, Wu J, et al. LncRNA PVT1 promotes angiogenesis via activating the STAT3\/VEGFA axis in gastric cancer. Oncogene. 2018;37:4094\u20134109. Nature Publishing Group.","DOI":"10.1038\/s41388-018-0250-z"},{"key":"1187_CR126","doi-asserted-by":"publisher","first-page":"5418","DOI":"10.12659\/MSM.917601","volume":"25","author":"Z Mao","year":"2019","unstructured":"Mao Z, Xu B, He L, Zhang G. PVT1 promotes angiogenesis by regulating miR-29c\/vascular endothelial growth factor (VEGF) signaling pathway in non-small-cell lung cancer (NSCLC). Med Sci Monit. 2019;25:5418\u201325 International Scientific Information, Inc.","journal-title":"Med Sci Monit"},{"key":"1187_CR127","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.omtn.2018.10.001","volume":"13","author":"Y Yu","year":"2018","unstructured":"Yu Y, Zhang M, Liu J, Xu B, Yang J, Wang N, et al. Long non-coding RNA PVT1 promotes cell proliferation and migration by silencing ANGPTL4 expression in cholangiocarcinoma. Mol Ther - Nucleic Acids. 2018;13:503\u201313 Cell Press.","journal-title":"Mol Ther - Nucleic Acids"},{"key":"1187_CR128","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/bs.ircmb.2014.10.004","volume":"314","author":"D Ribatti","year":"2015","unstructured":"Ribatti D, Nico B, Vacca A. Multiple myeloma as a model for the role of bone marrow niches in the control of angiogenesis. Int Rev Cell Mol Biol. 2015;314:259\u201382 Elsevier Inc.","journal-title":"Int Rev Cell Mol Biol"},{"key":"1187_CR129","doi-asserted-by":"crossref","unstructured":"Colombo M, Giannandrea D, Lesma E, Basile A, Chiaramonte R. Extracellular vesicles enhance multiple myeloma metastatic dissemination. Int J Mol Sci. 2019;20(13). MDPI AG.","DOI":"10.3390\/ijms20133236"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-020-01187-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12943-020-01187-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-020-01187-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T19:38:41Z","timestamp":1617046721000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/s12943-020-01187-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,30]]},"references-count":129,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1187"],"URL":"https:\/\/doi.org\/10.1186\/s12943-020-01187-5","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,30]]},"assertion":[{"value":"18 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"GM reports personal fees from Amgen, personal fees from Incyte, Pfizer, Celgene, Janssen, Jazz Pharmaceuticals, Abbvie, Novartis, Daiichi Sankyo, Amgen outside the submitted work. The other authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"69"}}